![Suyash Prasad](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Suyash Prasad
Corporate Officer/Principal bei
The Royal College of Physicians
Profil
Suyash Prasad is a Member at The Royal College of Physicians and The Royal College of Paediatrics & Child Health.
He is also the Principal at Dr. Prasad Consulting LLC since 2019.
Previously, he worked as the Senior Group Medical Director-Development Sciences at BioMarin Pharmaceutical, Inc. from 2010 to 2014.
He was also the Director-Global Medical Affairs at Genzyme Corp.
from 2009 to 2010.
Additionally, he served as the Chief Medical Officer & Senior Vice President at Astellas Gene Therapies, Inc. from 2014 to 2019.
Currently, he is the Chief Medical Officer at Taysha Gene Therapies, Inc. from 2022 to 2023.
Dr. Prasad holds a doctorate degree from Newcastle University and a graduate degree from King's College London.
Aktive Positionen von Suyash Prasad
| Unternehmen | Position | Beginn |
|---|---|---|
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Royal College of Paediatrics & Child Health
 The Royal College of Paediatrics & Child Health Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Suyash Prasad Consulting LLC | Corporate Officer/Principal | 01.10.2019 |
Ehemalige bekannte Positionen von Suyash Prasad
| Unternehmen | Position | Ende |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 12.01.2023 |
| AUDENTES THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 30.06.2019 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01.02.2014 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2010 |
National Pku Alliance
 National Pku Alliance The National PKU Alliance (NPKUA) is an independent nonprofit organization dedicated to supporting individuals and families affected by phenylketonuria (PKU), a rare inherited metabolic disorder. The private company is based in Eau Claire, WI. The organization’s mission includes community engagement, education, advocacy, and advancing research toward improved treatments and a cure for PKU. NPKUA operates a network of regional affiliates to provide local support and resources, offers patient registries, no-cost genetic testing for eligible individuals, treatment information, and clinical trial recruitment. It funds PKU research through a grant program and supports early-stage biotech companies developing therapies. NPKUA maintains a scientific advisory board, hosts annual scientific conferences, and provides community programs such as peer support group calls, a mentor program, PKU awareness events, and practical resources like support kits and dietary tools. The company was founded by Dick Michaux. | Direktor/Vorstandsmitglied | - |
Ausbildung von Suyash Prasad
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Newcastle University
 Newcastle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Eli Lilly & Co. Ltd.
 Eli Lilly & Co. Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical health care solutions | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
 King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Paediatrics & Child Health
The Royal College of Paediatrics & Child Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
National Pku Alliance
National Pku Alliance The National PKU Alliance (NPKUA) is an independent nonprofit organization dedicated to supporting individuals and families affected by phenylketonuria (PKU), a rare inherited metabolic disorder. The private company is based in Eau Claire, WI. The organization’s mission includes community engagement, education, advocacy, and advancing research toward improved treatments and a cure for PKU. NPKUA operates a network of regional affiliates to provide local support and resources, offers patient registries, no-cost genetic testing for eligible individuals, treatment information, and clinical trial recruitment. It funds PKU research through a grant program and supports early-stage biotech companies developing therapies. NPKUA maintains a scientific advisory board, hosts annual scientific conferences, and provides community programs such as peer support group calls, a mentor program, PKU awareness events, and practical resources like support kits and dietary tools. The company was founded by Dick Michaux. | |
Taysha Gene Therapies, Inc.
 Taysha Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes adeno-associated viruses-based gene therapies for the treatment of monogenic diseases of the central nervous system | Health Technology |
Suyash Prasad Consulting LLC |
